Head of Technology and Regulatory Policy
Roche

Thomas Schreitmüller holds a Diploma and PhD in Biochemistry from the University of Munich (Max Planck Institute for Biochemistry, Munich, Martinsried and Institute for Clinical Chemistry and Clinical Biochemistry University of Munich). In 1989 he joined Roche holding various positions in the biotech area (e.g. analytical development, technical project management).
Since 2003 Thomas was heading the department "Analytical R&D and Quality Control Biotech Products" at Roche Pharma Technical Operations in Basel, Switzerland. The department assumes responsibility for basic analytical research in the context of biotech products, is doing the analytical development and quality control of biotech development products and clinical supplies respectively, and is responsible for the quality control of Roche marketed biotech products (e.g. Roferon-A, Neupogen, Zenapax, Herceptin, Mabthera, Pegasys, Avastin…) manufactured at Roche Basel.

Since 2010 Thomas is the global lead for technical regulatory policy and strategy for biologics within Roche.